中药配合髓芯减压术治疗激素性股骨头坏死的临床及实验研究
|
摘要
激素性股骨头坏死属难治疾病,发病率和致残率高,严重影响患者的生活质量。但激素性股骨头坏死确切的发病机制尚未十分清楚,限制了预防和治疗工作的开展。手术是遏制激素性股骨头坏死进程和防止塌陷的基本方法和前提,但有其自身的局限性。中医药治疗激素性股骨头坏死有着显著优势,疗效满意,但单纯中医治疗也存在不足。探讨如何将西医手术和中医药的治疗优势有机结合,寻求一种疗效确切,费用低廉,副作用少的综合疗法,对于提高治疗激素性股骨头缺血性坏死的疗效,减轻患者和社会经济负担具有重要意义。
1.目的:以激素性股骨头坏死为研究对象,通过文献分析、实验研究和临床观察,对中西医治疗SANFH的结合点进行探讨,以期建立治疗SANFH的独特指导原则,为临床选择合适的治疗方案、合理用药,提供新的思路。
2.方法:
2.1理论研究:采用文献学、逻辑分析等方法,对中、西医对激素性股骨头坏死病因病机的各自认识、治疗现状及前期的实验结果进行阐释和分析,提出中西医结合治疗激素性股骨头坏死的可行性思路和途径,并对其二者的结合点进行探讨。
2.2临床研究:
(1)总体思路:SANFH的治疗一直是医学界的难点,手术是遏制SANFH进程和防止塌陷的基本方法和前提,但有其自身的局限性。中医药治疗SANFH有着双向调节作用,但是单纯中医治疗也存在不足。本研究课题所在单位已经在骨坏死的中西医结合治疗领域进行了全面扎实的前期探索性基础和临床研究工作。从2003年起,对激素性股骨头坏死患者进行了髓芯减压术,同时配合口服木豆叶与中医康复治疗,取得了良好的治疗效果。本研究通过对近年来综合疗法治疗激素性股骨头坏死的病历进行回顾分析,以完成中药配合髓芯减压术治疗SANFH的疗效评估,并在此基础上总结治疗经验和规律,以指导进一步临床应用和研究。
(2)一般资料:以激素性股骨头坏死病人为观察对象,按照诊断标准,纳入标准及排除标准,选择2003年-2006年东直门医院激素性股骨头坏死患者共58例。
(3)调查指标:一般项目包括患者姓名、性别、年龄、职业、入院明确诊断、治疗方案等。调查项目包括肾功能指标、生化指标、效性指标、影像学指标及综合临床疗效评定指标。
(4)统计方法:运用SPSS13.0分析软件进行T检验和单因素方差分析。
2.3实验研究:
(1)总体设计:本实验研究主要以建立与人类SANFH有相似性和可比性、符合人类SANFH病变的客观规律、经济可行的动物模型为切入点,选择了与激素性股骨头坏死密切相关的VEGF及相关细胞因子作为研究的对象。观察在激素冲击下,所观测指标(组织形态、VEGF、BMP-2)在采用不同治法下治疗前后的变化,并对其相关性进行了比较分析。
(2)实验动物:健康新西兰大耳兔,雄性,4周龄,体重0.60±0.11kg。将所用新西兰大耳兔置入特制的笼中,自然光照,自由摄取食水,室温饲养。造成直立行走兔模型;参照贺氏造模法,肌注醋酸泼尼松龙8mg/kg/次,每周两次,连续注射8w。造模成功后,经影像学检查,参照国际ARCO分期标准进行分期。随机分组后,进行中药、手术及综合治疗。
(3)检测方法:病理组织学检查,运用光镜、电镜观察;动态血清中BMP-2测定,运用放射免疫法。VEGF和BMP-2测定,运用免疫组化法;
(4)分析方法:所有数据以(?)±SE表示,组间差异利用SPSS13.0统计软件包进行ANOVA检验,以P＜0.05差异为有显著性。变量关系采用直线相关分析。
3.结果:
3.1理论研究结果:
激素性股骨头坏死属临床难治疾病,发病率和致残率高,严重影响人们的生活质量。但激素性股骨头坏死确切的发病机制尚未十分清楚,限制了临床预防和治疗工作的开展。手术是遏制激素性股骨头坏死进程和防止塌陷的基本方法和前提,但有其自身的局限性。中医药治疗激素性股骨头坏死有着显著优势,但单纯中医治疗也存在不足。要创立治疗激素性股骨头坏死的独特指导原则,关键在中西医治疗激素性股骨头坏死的结合点的确定。或许通过西医的手段,创造有利于股骨头坏死组织修复的局部环境,再加上中医药的促进作用,能达到事半功倍的效果。股骨头坏死的动物模型对探索成功的治疗模式是必不可少的,新的治疗方法的探索因缺乏与人股骨头坏死相一致的动物模型而受阻碍。如何制造出更符合人类股骨头坏死发展的动物模型,是一个迫切需要解决的问题。
3.2临床研究结果:
3.2.1治疗前后Harris评分变化
Harris评分显示:中药组临床治愈9髋,显效2髋,有效4髋,无效7髋;手术组临床治愈3髋,显效3髋,有效9髋,无效5髋;综合组临床治愈11髋,显效5髋,有效4髋,无效5髋。
3.2.2三组影像学疗效比较
影像学指标:中药组显效8髋,有效8髋,无效6髋;手术组影像学指标显效10髋,有效4髋,无效6髋;综合组影像学指标显效13髋,有效6髋,无效3髋。
3.2.3三组总疗效比较
综合临床疗效评定显示:中药组显效8髋,有效8髋,无效6髋,总有效率72.72%;手术组显效6髋,有效9髋,无效5髋。总有效率75.00%;综合组显效11髋,有效11髋,无效3髋。总有效率88.00%。
3.3实验研究结果
3.3.1 VEGF表达水平:模型组VEGF表达水平在第二周时较空白组升高,但第四、八周VEGF表达水平逐渐降低,明显低于空白组。
3.3.2血清BMP-2含量:模型组血清BMP-2含量较空白组降低,其差异有显著性(P＜0.01)。
3.3.3中药组、手术组和综合组BMP-2水平均较模型组升高,有显著性差异(P＜0.01),说明三者均能通过升高BMP-2水平来治疗激素性INFH;中药组、手术组和综合组比较而言,综合组BMP-2水平升高最为明显,和其他两组相比有显著性差异。中药组BMP-2水平稍高于手术组,但二者相比,其差异无统计学意义。
4.结论:
4.1激素很可能是通过抑制VEGF的表达而使股骨头缺血性坏死的血管无法再生,减少血供,导致骨细胞死亡,继而发生股骨头缺血性坏死。
4.2 BMP-2水平降低可能是激素性INFH发生的因素之一。
4.3中药配合髓苍减压术治疗是治疗激素性股骨头坏死的最佳选择。
Steroid-induced Avascular Necrosis of the Femoral Head(SANFH)is a kind of refractoriness disease,whose attack rate and mutilation rate are very high,which seriously affect patient's living quality.But the exact nosogenesis of SANFH is not fully understanded.Which restrict the development of prophylaxis and cure method.Operation is the basic method and premise,but operation is also local.Traditional Chinese medicine has notable superiority to cure SANFH,it's curative effect is content.But cure method only by TCM also has it's insufficiency. To study how to combine operation and TCM,seek a combined therapy which has certain curative effect,low cost and few side effect,is important to raise cure effect of SANFH, economics burden of patient and society lessen.
1 Objective
By literature analysis,empirical study and clinical observation,to study the cure SANFH method by combining site of modern and TCM,expect to found the guide principle of cure SANFH,provide new method for clinical select suitable treatment plan and rational use.
2 Method
2.1 Theory research
By method of bibliography and logic analysis,explain and analysis each recognition to etiological and pathogeny,cure status quo of SANFH and prophase experiment result,provide think method and way to cure SANFH by combination of TCM with Western medicine,and study the combining site.
2.2 clinical research
(1)overall thinking route:SANFH treatment has been the medical arena difficulty,surgery is the essential method and premise contains the SANFH advancement and prevents the collapse, but has its own limitation.Chinese medicine has the bidirectional control action to SANFH treat, but the pure Chinese medicine treatment also has the insufficiency.This research subject had already carried on the comprehensive solid preliminary exploring foundation and the clinical research work in the osteonecrosis cooperation of Chinese and Western medicine treatment domain.From 2003,has carried on the Core Decompression technique to the Steroid-induced Avascular Necrosis of the Femoral Head patient,simultaneously coordinated the Mu Dou leaf and the Chinese medicine recovery treatment,has obtained the good treatment result.This research through carring on the review analysis to the recent years composite treatment Steroid-induced Avascular Necrosis of the Femoral Head's medical record,completed the traditional Chinese medicine coordination Core Decompression technique to treat SANFH the curative effect appraisal,based on this and summarized the treatment experience and the rule, instructed further clinical practice and research..
(2)common material:Take the Steroid-induced Avascular Necrosis of the Femoral Head patient as the object of observation,according to the diagnosis standard,integrates the standard and the elimination standard,chose 2003-2006 Steroid-induced Avascular Necrosis of the Femoral Head patient altogether 58 examples of the Dongzhimen hospital.
(3)investigates the target:Generally the project including the patient name,the sex,the age, the occupation,is hospitalized to be clear about the diagnosis,the therapeutic schedule and so on.Investigation project including kidney function target,biochemistry target,effect target, phantom study target and synthesis clinical curative effect deliberated index
(4)statistical method:Carries on the T-test and the single factor variance analysis using the SPSS 13.0 analysis software.
2.3 Experimental studies:
(1)General layout:This experimental study mainly take establishes with human SANFH has the similarity and the commeasurability,conforms to the human SANFH pathological change's objective law,the economical feasible animal model as a breakthrough point,has chosen takes the research with Steroid-induced Avascular Necrosis of the Femoral Head close related VEGF and the correlation cell factor the object.Around the observation under the hormone impact, observes the target(organization shape,VEGF,BMP-2)change that before and after using different treat law,and has carried on the comparative analysis to its relevance.
(2)Animal experimental:Health New Zealand big ear rabbit,male gender,4 week age,body weight 0.60±0.11kg.New Zealand big ear rabbit will be post specially made cage,the natural illumination,the freedom absorbs the drinking water,room temperature raising.Refers to He's making mold law,intermuscular injection acetic acid Prednisone dragon 8mg/kg/time,two times every week,injects 8w continuously.After making the mold success,after the phantom study inspection,reference international the ARCO standard carries on by stages by stages. After stochastic grouping,carries on the traditional Chinese medicine,the surgery and the complex therapy.
3)Examination method:The histo-pathology inspection,utilizes the light microscope,the electron microscope observation;VEGF determination,utilization immunity group reduction; Blood serum BMP-2 determination,utilization emission immunization technology.
(4)Analysis method:All data by~(?)±SE the expression,the group difference carry on the ANOVA examination that using the SPSS13.0 statistics software package,The difference has the significance by P＜0.05.The variable relations use the straight line correlation analysis.
3.Result:
3.1 Fundamental research result
Steroid-induced Avascular Necrosis of the Femoral Head is clinical difficult to be treated disease, the disease incidence rate and crippling rate is very high,serious influence people's life quality. But the Steroid-induced Avascular Necrosis of the Femoral Head accurate pathogenesis was not yet clear,this limit the clinical prevention and the treatment work development.Surgery is contains the h Steroid-induced Avascular Necrosis of the Femoral Head advancement and prevents the collapse the essential method and the premise,but has its own limitation.Chinese medicine treatment Steroid-induced Avascular Necrosis of the Femoral Head has the remarkable superiority,but the pure Chinese medicine treatment also has the insufficiency.The unique guiding principle treatment Steroid-induced Avascular Necrosis of the Femoral Head's must be establish,the key treat Must establish's combining site determination in the doctor practicing between Chinese medicine and western medicine.Through doctor western medicine's method practicing,Creation advantageous that perhaps is the local environment which organizes to be repaired,in addition Chinese medicine promoter action,can achieve the twice result with half the effort effect.The animal model to explores the successful treatment pattern is essential,the new method of treatment's exploration because of lacks receives with the annual bonus bone necrosis consistent animal model hinders.How to make conforms to the animal model which human Must establish develops,is a question which urgent needs to be solved.
3.2 Clinical research results:
3.2.1 Harris grading changes prior-treatment and post-treatment
The Harris grading to demonstrate:The traditional Chinese medicine group clinical cures 9 hips,excellent results 2 hips,effective 4 hips,invalid 7 hips;The surgery group clinical cures 3 hips,excellent results 3 hips,effective 9 hips,invalid 5 hips;The comprehensive group clinical cures 11 hips,excellent results 5 hips,effective 4 hips,invalid 5 hips. 3.2.2 Three group of imaging study curative effects compare the phantom study target: The traditional Chinese medicine group shows results 8 hips,effective 8 hips,invalid 6 hips; The surgery group phantom study target shows results 10 hips,effective 4 hips,invalid 6 hips; The comprehensive group phantom study target shows results 13 hips,effective 6 hips,invalid 3 hips.3.2.3Three groups of total curative effects compare demonstrate:
The traditional Chinese medicine group shows results 8 hips,effective 8 hips,invalid 6 hips, total effectiveness 72.72%;The surgery group shows results 6 hips,effective 9 hips,invalid 5 hips.Total effectiveness 75.00%;the synthesis group shows results 11 hips,effective 11 hips, invalid 3 hips.Total effectiveness 88.00%.
3.3 Experimental study result
3.3.1 VEGF expression level:Model group VEGF expression level compares the blank group elevate after the second week,but the fourth,eighth week VEGF expression level reduces gradually,lower the blank group obviously.
3.3.2 BMP-2 content:The model group blood serum BMP-2 content compares the blank group to reduce,its difference has the significance(P＜0.01).
3.3.3 Traditional Chinese medicine groups,the surgery group and the synthesis group BMP-2 water elevate mean difference to model group,has the significance difference(P＜0.01). Explained that three can through elevate the BMP-2 level to treat hormone nature INFH;the comprehensive group BMP-2 level elevates obviously,compares with other two groups has the significance difference.The traditional Chinese medicine group BMP-2 level is higher than the surgery group slightly,but the two compare,its difference non-statistics significance.
4 Conclusion:
4.1 Hormone make avascular necrosis of the femoral head's blood vessel has no way to regenerate might by restraint VEGF express,reduce blood supply,result in osteocyte death,and continue make avascular necrosis of the femoral head.
4.2 BMP-2 level cut down might be one of the factors of SANFH.
4.3 Traditional Chinese medicine coordination Core Decompression technique to treat SANFH is the best method to treat Steroid-induced Avascular Necrosis of the Femoral Head.
1.目的:以激素性股骨头坏死为研究对象,通过文献分析、实验研究和临床观察,对中西医治疗SANFH的结合点进行探讨,以期建立治疗SANFH的独特指导原则,为临床选择合适的治疗方案、合理用药,提供新的思路。
2.方法:
2.1理论研究:采用文献学、逻辑分析等方法,对中、西医对激素性股骨头坏死病因病机的各自认识、治疗现状及前期的实验结果进行阐释和分析,提出中西医结合治疗激素性股骨头坏死的可行性思路和途径,并对其二者的结合点进行探讨。
2.2临床研究:
(1)总体思路:SANFH的治疗一直是医学界的难点,手术是遏制SANFH进程和防止塌陷的基本方法和前提,但有其自身的局限性。中医药治疗SANFH有着双向调节作用,但是单纯中医治疗也存在不足。本研究课题所在单位已经在骨坏死的中西医结合治疗领域进行了全面扎实的前期探索性基础和临床研究工作。从2003年起,对激素性股骨头坏死患者进行了髓芯减压术,同时配合口服木豆叶与中医康复治疗,取得了良好的治疗效果。本研究通过对近年来综合疗法治疗激素性股骨头坏死的病历进行回顾分析,以完成中药配合髓芯减压术治疗SANFH的疗效评估,并在此基础上总结治疗经验和规律,以指导进一步临床应用和研究。
(2)一般资料:以激素性股骨头坏死病人为观察对象,按照诊断标准,纳入标准及排除标准,选择2003年-2006年东直门医院激素性股骨头坏死患者共58例。
(3)调查指标:一般项目包括患者姓名、性别、年龄、职业、入院明确诊断、治疗方案等。调查项目包括肾功能指标、生化指标、效性指标、影像学指标及综合临床疗效评定指标。
(4)统计方法:运用SPSS13.0分析软件进行T检验和单因素方差分析。
2.3实验研究:
(1)总体设计:本实验研究主要以建立与人类SANFH有相似性和可比性、符合人类SANFH病变的客观规律、经济可行的动物模型为切入点,选择了与激素性股骨头坏死密切相关的VEGF及相关细胞因子作为研究的对象。观察在激素冲击下,所观测指标(组织形态、VEGF、BMP-2)在采用不同治法下治疗前后的变化,并对其相关性进行了比较分析。
(2)实验动物:健康新西兰大耳兔,雄性,4周龄,体重0.60±0.11kg。将所用新西兰大耳兔置入特制的笼中,自然光照,自由摄取食水,室温饲养。造成直立行走兔模型;参照贺氏造模法,肌注醋酸泼尼松龙8mg/kg/次,每周两次,连续注射8w。造模成功后,经影像学检查,参照国际ARCO分期标准进行分期。随机分组后,进行中药、手术及综合治疗。
(3)检测方法:病理组织学检查,运用光镜、电镜观察;动态血清中BMP-2测定,运用放射免疫法。VEGF和BMP-2测定,运用免疫组化法;
(4)分析方法:所有数据以(?)±SE表示,组间差异利用SPSS13.0统计软件包进行ANOVA检验,以P＜0.05差异为有显著性。变量关系采用直线相关分析。
3.结果:
3.1理论研究结果:
激素性股骨头坏死属临床难治疾病,发病率和致残率高,严重影响人们的生活质量。但激素性股骨头坏死确切的发病机制尚未十分清楚,限制了临床预防和治疗工作的开展。手术是遏制激素性股骨头坏死进程和防止塌陷的基本方法和前提,但有其自身的局限性。中医药治疗激素性股骨头坏死有着显著优势,但单纯中医治疗也存在不足。要创立治疗激素性股骨头坏死的独特指导原则,关键在中西医治疗激素性股骨头坏死的结合点的确定。或许通过西医的手段,创造有利于股骨头坏死组织修复的局部环境,再加上中医药的促进作用,能达到事半功倍的效果。股骨头坏死的动物模型对探索成功的治疗模式是必不可少的,新的治疗方法的探索因缺乏与人股骨头坏死相一致的动物模型而受阻碍。如何制造出更符合人类股骨头坏死发展的动物模型,是一个迫切需要解决的问题。
3.2临床研究结果:
3.2.1治疗前后Harris评分变化
Harris评分显示:中药组临床治愈9髋,显效2髋,有效4髋,无效7髋;手术组临床治愈3髋,显效3髋,有效9髋,无效5髋;综合组临床治愈11髋,显效5髋,有效4髋,无效5髋。
3.2.2三组影像学疗效比较
影像学指标:中药组显效8髋,有效8髋,无效6髋;手术组影像学指标显效10髋,有效4髋,无效6髋;综合组影像学指标显效13髋,有效6髋,无效3髋。
3.2.3三组总疗效比较
综合临床疗效评定显示:中药组显效8髋,有效8髋,无效6髋,总有效率72.72%;手术组显效6髋,有效9髋,无效5髋。总有效率75.00%;综合组显效11髋,有效11髋,无效3髋。总有效率88.00%。
3.3实验研究结果
3.3.1 VEGF表达水平:模型组VEGF表达水平在第二周时较空白组升高,但第四、八周VEGF表达水平逐渐降低,明显低于空白组。
3.3.2血清BMP-2含量:模型组血清BMP-2含量较空白组降低,其差异有显著性(P＜0.01)。
3.3.3中药组、手术组和综合组BMP-2水平均较模型组升高,有显著性差异(P＜0.01),说明三者均能通过升高BMP-2水平来治疗激素性INFH;中药组、手术组和综合组比较而言,综合组BMP-2水平升高最为明显,和其他两组相比有显著性差异。中药组BMP-2水平稍高于手术组,但二者相比,其差异无统计学意义。
4.结论:
4.1激素很可能是通过抑制VEGF的表达而使股骨头缺血性坏死的血管无法再生,减少血供,导致骨细胞死亡,继而发生股骨头缺血性坏死。
4.2 BMP-2水平降低可能是激素性INFH发生的因素之一。
4.3中药配合髓苍减压术治疗是治疗激素性股骨头坏死的最佳选择。
Steroid-induced Avascular Necrosis of the Femoral Head(SANFH)is a kind of refractoriness disease,whose attack rate and mutilation rate are very high,which seriously affect patient's living quality.But the exact nosogenesis of SANFH is not fully understanded.Which restrict the development of prophylaxis and cure method.Operation is the basic method and premise,but operation is also local.Traditional Chinese medicine has notable superiority to cure SANFH,it's curative effect is content.But cure method only by TCM also has it's insufficiency. To study how to combine operation and TCM,seek a combined therapy which has certain curative effect,low cost and few side effect,is important to raise cure effect of SANFH, economics burden of patient and society lessen.
1 Objective
By literature analysis,empirical study and clinical observation,to study the cure SANFH method by combining site of modern and TCM,expect to found the guide principle of cure SANFH,provide new method for clinical select suitable treatment plan and rational use.
2 Method
2.1 Theory research
By method of bibliography and logic analysis,explain and analysis each recognition to etiological and pathogeny,cure status quo of SANFH and prophase experiment result,provide think method and way to cure SANFH by combination of TCM with Western medicine,and study the combining site.
2.2 clinical research
(1)overall thinking route:SANFH treatment has been the medical arena difficulty,surgery is the essential method and premise contains the SANFH advancement and prevents the collapse, but has its own limitation.Chinese medicine has the bidirectional control action to SANFH treat, but the pure Chinese medicine treatment also has the insufficiency.This research subject had already carried on the comprehensive solid preliminary exploring foundation and the clinical research work in the osteonecrosis cooperation of Chinese and Western medicine treatment domain.From 2003,has carried on the Core Decompression technique to the Steroid-induced Avascular Necrosis of the Femoral Head patient,simultaneously coordinated the Mu Dou leaf and the Chinese medicine recovery treatment,has obtained the good treatment result.This research through carring on the review analysis to the recent years composite treatment Steroid-induced Avascular Necrosis of the Femoral Head's medical record,completed the traditional Chinese medicine coordination Core Decompression technique to treat SANFH the curative effect appraisal,based on this and summarized the treatment experience and the rule, instructed further clinical practice and research..
(2)common material:Take the Steroid-induced Avascular Necrosis of the Femoral Head patient as the object of observation,according to the diagnosis standard,integrates the standard and the elimination standard,chose 2003-2006 Steroid-induced Avascular Necrosis of the Femoral Head patient altogether 58 examples of the Dongzhimen hospital.
(3)investigates the target:Generally the project including the patient name,the sex,the age, the occupation,is hospitalized to be clear about the diagnosis,the therapeutic schedule and so on.Investigation project including kidney function target,biochemistry target,effect target, phantom study target and synthesis clinical curative effect deliberated index
(4)statistical method:Carries on the T-test and the single factor variance analysis using the SPSS 13.0 analysis software.
2.3 Experimental studies:
(1)General layout:This experimental study mainly take establishes with human SANFH has the similarity and the commeasurability,conforms to the human SANFH pathological change's objective law,the economical feasible animal model as a breakthrough point,has chosen takes the research with Steroid-induced Avascular Necrosis of the Femoral Head close related VEGF and the correlation cell factor the object.Around the observation under the hormone impact, observes the target(organization shape,VEGF,BMP-2)change that before and after using different treat law,and has carried on the comparative analysis to its relevance.
(2)Animal experimental:Health New Zealand big ear rabbit,male gender,4 week age,body weight 0.60±0.11kg.New Zealand big ear rabbit will be post specially made cage,the natural illumination,the freedom absorbs the drinking water,room temperature raising.Refers to He's making mold law,intermuscular injection acetic acid Prednisone dragon 8mg/kg/time,two times every week,injects 8w continuously.After making the mold success,after the phantom study inspection,reference international the ARCO standard carries on by stages by stages. After stochastic grouping,carries on the traditional Chinese medicine,the surgery and the complex therapy.
3)Examination method:The histo-pathology inspection,utilizes the light microscope,the electron microscope observation;VEGF determination,utilization immunity group reduction; Blood serum BMP-2 determination,utilization emission immunization technology.
(4)Analysis method:All data by~(?)±SE the expression,the group difference carry on the ANOVA examination that using the SPSS13.0 statistics software package,The difference has the significance by P＜0.05.The variable relations use the straight line correlation analysis.
3.Result:
3.1 Fundamental research result
Steroid-induced Avascular Necrosis of the Femoral Head is clinical difficult to be treated disease, the disease incidence rate and crippling rate is very high,serious influence people's life quality. But the Steroid-induced Avascular Necrosis of the Femoral Head accurate pathogenesis was not yet clear,this limit the clinical prevention and the treatment work development.Surgery is contains the h Steroid-induced Avascular Necrosis of the Femoral Head advancement and prevents the collapse the essential method and the premise,but has its own limitation.Chinese medicine treatment Steroid-induced Avascular Necrosis of the Femoral Head has the remarkable superiority,but the pure Chinese medicine treatment also has the insufficiency.The unique guiding principle treatment Steroid-induced Avascular Necrosis of the Femoral Head's must be establish,the key treat Must establish's combining site determination in the doctor practicing between Chinese medicine and western medicine.Through doctor western medicine's method practicing,Creation advantageous that perhaps is the local environment which organizes to be repaired,in addition Chinese medicine promoter action,can achieve the twice result with half the effort effect.The animal model to explores the successful treatment pattern is essential,the new method of treatment's exploration because of lacks receives with the annual bonus bone necrosis consistent animal model hinders.How to make conforms to the animal model which human Must establish develops,is a question which urgent needs to be solved.
3.2 Clinical research results:
3.2.1 Harris grading changes prior-treatment and post-treatment
The Harris grading to demonstrate:The traditional Chinese medicine group clinical cures 9 hips,excellent results 2 hips,effective 4 hips,invalid 7 hips;The surgery group clinical cures 3 hips,excellent results 3 hips,effective 9 hips,invalid 5 hips;The comprehensive group clinical cures 11 hips,excellent results 5 hips,effective 4 hips,invalid 5 hips. 3.2.2 Three group of imaging study curative effects compare the phantom study target: The traditional Chinese medicine group shows results 8 hips,effective 8 hips,invalid 6 hips; The surgery group phantom study target shows results 10 hips,effective 4 hips,invalid 6 hips; The comprehensive group phantom study target shows results 13 hips,effective 6 hips,invalid 3 hips.3.2.3Three groups of total curative effects compare demonstrate:
The traditional Chinese medicine group shows results 8 hips,effective 8 hips,invalid 6 hips, total effectiveness 72.72%;The surgery group shows results 6 hips,effective 9 hips,invalid 5 hips.Total effectiveness 75.00%;the synthesis group shows results 11 hips,effective 11 hips, invalid 3 hips.Total effectiveness 88.00%.
3.3 Experimental study result
3.3.1 VEGF expression level:Model group VEGF expression level compares the blank group elevate after the second week,but the fourth,eighth week VEGF expression level reduces gradually,lower the blank group obviously.
3.3.2 BMP-2 content:The model group blood serum BMP-2 content compares the blank group to reduce,its difference has the significance(P＜0.01).
3.3.3 Traditional Chinese medicine groups,the surgery group and the synthesis group BMP-2 water elevate mean difference to model group,has the significance difference(P＜0.01). Explained that three can through elevate the BMP-2 level to treat hormone nature INFH;the comprehensive group BMP-2 level elevates obviously,compares with other two groups has the significance difference.The traditional Chinese medicine group BMP-2 level is higher than the surgery group slightly,but the two compare,its difference non-statistics significance.
4 Conclusion:
4.1 Hormone make avascular necrosis of the femoral head's blood vessel has no way to regenerate might by restraint VEGF express,reduce blood supply,result in osteocyte death,and continue make avascular necrosis of the femoral head.
4.2 BMP-2 level cut down might be one of the factors of SANFH.
4.3 Traditional Chinese medicine coordination Core Decompression technique to treat SANFH is the best method to treat Steroid-induced Avascular Necrosis of the Femoral Head.
引文
[1]邓沂,张晓刚,任远,等.中医对股骨头坏死的认识.甘肃中医学院学报,1998,15(4):54-56.
[2]刘少军,袁浩.股骨头坏死的中医临床思路与方法探讨.中国医药学报,2002,17(1):44-47.
[3]左萍萍,吴业华,李学坤,等.新骨生胶囊治疗股骨头坏死的药理研究.中国康复理论与实验,2002,8(1):11-12.
[4]茆军,郭玉成.补肾通络汤治疗早期非创伤性股骨头坏死的临床研究.河北医学,2002,8(7):672-673.
[5]齐振熙,曹阳.不同治法对激素性股骨头坏死血液流变学及血脂影响的实验研究.中国中医骨伤科杂志,2001,9(5):39-31.
[6]曾炎辉.补肾活血汤治疗中老年股骨头缺血性坏死临床观察.广州中医药大学学报,2005,22(2):96.
[7]李清文,激素性股骨头缺血性坏死微观瘀血诊治之我见.湖南中医学院学报.1999:19(1):28-29
[8]何维英,季卫峰,童培建.保守治疗股骨头坏死的疗效观察.浙江中医学院学报,2003,27(5):33.
[9]肖正权.健骨颗粒治疗无菌性股骨头坏死120例临床观察.中医药学报,2002,30(4):33.
[10]洪加源,许书亮,阮景绰,等.复元散对激素性股骨头坏死脂代谢的影响.中医正骨,2001,13(4):6-8.
[11]王玉华.浅述SARS愈后股骨头坏死的综合治疗.北京中医药大学学报(中医临床版),2004,9,11(3):35-36.
[12]邓沂,张晓刚,任远,等.中医对股骨头坏死的认识.甘肃中医学报,1988, 15(4):54-56.
[13]徐传毅.袁浩教授以血瘀论治激素性股骨头坏死经验.中医约学刊,2003,21(2):194-195.
[14]刘少军,袁浩.股骨头坏死的中医临床思路与方法探讨.中国医药学报,2002,17(1):44-47.
[15]乔美莲.针灸治疗激素性股骨头坏死.山西中医学院学报,2003,4(2):34.
[16]张晓刚,任远,王刚,等.生骨再造散对激素性股骨头坏死家兔血脂的影响.中国骨伤,2001,14(3):148-149.
[17]汤耿民,王胜利,李同生,等.健骨生丸治疗股骨头坏死Ⅱ期临床研究,中国中医骨伤科杂志,1998,6(1):16-19
[18]王峰,丁锷,李保泉.股骨头缺血性坏死的中医分型和治疗.中医正骨,2005,17(7):24.
[19]马素英.马氏骨片治疗激素性股骨头坏死1323例[J].中医骨伤,1993,6(3):32.
[20]张铁刚.股骨头坏死中医三型分治的临床总结[J].中国中医约结合外科杂志,1998,12(4):6
[21]李雄.袁浩教授对股骨头坏死中医药论治的学术思想[J].中国中医骨伤科,1999,7(1):61.
[22]王平,高红艳.辨证分型治疗激素性股骨头坏死117例[J].上海中医药大学学报,2003,17(1):36.
[23]王峰,周章武.丁锷教授诊治股骨头坏死学术经验[J].安徽中医学院学报,1999,18(5):47.
[24]王峰,丁锷,李保泉.股骨头缺血性坏死的中医分型和治疗.中医正骨,2005,17(7):24.
[25]杨晓娟.黄芪生骨汤治疗股骨头坏死179例疗效观察.时珍国医药.1998,9(6):503
[26]杨述华.骨坏死学[M].北京:人民卫生出版社,2002:7-8.
[1]Meyers MH.Osteonecrosis of the femoral head.Pathogenesis and Long-term results of treatment,[J].Clinical Orthopaedics snd Related Research,1988(231):51-61.
[2]Cruess RL,Osteonecrosis of bone.Current concepts as to etiology and pathogenesis.[J].Clinical Orthopaedics and Related Research,1986(208):30-39.
[3]林乔龄,张嵩图,陈联源,等.股骨头缺血坏死发病机理研究[J],中国骨伤,2001,14(3):150-151..
[4]洪加源,郭林新,康两期.激素性股骨头坏死骨代谢变化的实验研究[J].骨与关节损伤杂志,2001,26(5):365-368.
[5]Climcher MJ,Kenzora JE.The biology of ostenecrosis of the human femoral head and its clinical impalcations.Ⅲ.Discussion of the etiology and genesis of the pathological seguelae;comments on treatment[J],Clinical Orthopaedics and Related Research,1979(140):273-312.
[6]Jones JP.Fat embolism and osteonecrosis.[J].The Orthopedic Clinics of North America,1985,16(4):595-633.
[7]王坤正,毛履真,胡长根.激素性股骨头缺血性坏死发病机制的实验研究[J].中华外科杂志,1994,32(9):515-517.
[8]贺西京,毛履真,王坤正.激素性股骨头坏死与骨细胞脂肪变性的实验研究[J].中华骨科杂志,1996,16(1):44-46..
[9]文良元,黄公怡,路奎元.激素性股骨头坏死的发病机制研究[J].中华外科杂志,1998,36(1):39-41.
[10]Beisiegel U,Spector A.Bong:a forgotten organ in lipidology.[J].Curr Opin Lipidol,2002,13(3):239-240.
[11]Cui Q,Wang GJ,Balian G.Steroid-induced adipogenesis in a pluripotential cell line from bone marrow[J].J Bone Joint Surg Am,1997,79(7):1054-1063.
[12]Cui Q,Wang GJ,Balian G,Pluripotential marrow cells produce adipocytes when transplanted into steroid-treated mice[J].Cnonect Tissue Res,2000,41(1):45-56.
[13]Jones JP.Intravascular coagulation and osteonecrosis.[J].Clinical Orthopaedics and Related Research,1992(277):41-53.
[14]Jones JP.Fat embolism,intravascular coagulation,and osteonecrosis.[J].Clinical Orthopaedics and Related Research,1993(292):294-308.
[15]Jones JP.Concepts of etiology and early pathogenesis of osteonecrosis,[J].Instructional Course Lectures,1994,(43):499-512.
[16]Jones JP.Coagulopathies and osteonecrosis.[J].Acta Orthopaedica Belgica,1999,65Suppl 15-8.
[17]Jones LC,Mont MA,Le TB,et al.Procoagulants and osteonecrosis,[J].The Journal of Rheumatology,2003,30(4):783.
[18]Weinstein RS,Nicholas RW,Manolagas SC,Apoptosis of osteocytes in glucocorticoid-induced osteonecrosis of the hip.[J].The Journal of Clinical Endocrinology and Metabolism,2000,85(8):2907-2912.
[19]Agarwala S,Sule A,Pai BU,Joshi VR,et al.Study of alendronate in avascular necrosis of bone[J].J Assoc Physicians India,2001(49):949-950.
[20]Eberhardt AW,Yeager Jones A,Blair HC,Regional trabecular bone matrix degeneration and osteocyte death in femora of glucocorticoid-treated rabbits.[J].Endocrinology,2001,142(3):1333-1340.
[21]Pritchett JW.Statin therapy decreases the risk of osteonecrosis inpatients receiving steroids.Clin Orthop Relat Res,2001,38(6):173-178.
[22]王卫东,廖文胜,王义生.辛伐他汀预防激素性股骨头坏死的实验研究.郑州大学学报(医学版),2004,39(3):473-475.
[23]李卫哲,李景南,张新.抗凝药物预防激素所致股骨头坏死.吉林大学学报(医学版),2003,29(4):475-476.
[24]Masuhara K,Nakata K,Yamasaki S,et al.Involvement of plateletactivation in experimental osteonecrosis in rabbits.Int J ExpPathol,2001,82(5):303-308.
[25]李晓辉,炎跃昆,宋跃明.碱性成纤维细胞生长因子复合部分脱蛋白骨增强兔股骨头骨缺损修复作用的研究.中国修复重建外科杂志,2005,19(3):183-186.
[26]Whitlock PR,Hackett NR,Leopold PL,et al.Adenovirus-medi-ated transfer of a minigene expressing multiple isoforms of VEGF is more effective at inducing angiogenesis than comparable vectors expressing individual VEGF cDNAs.Mol The,2004,9(1):67-75.
[27]Nakagawa M,Kaneda T,Arakawa T,et al.Vascular endothelialgrowth factor directly enhances osteoclastic bone resorption and sur-vival of mature osteoclasts.Febs Letters,2000,473(3):161-164.
[28]ZhanQx,MagovernCJ,MackCA,etal.Vascularendothelialgrowthfactorangiogenesis[J].J Su rgRes,1997,67:147-154.
[29]NapoleoneFerrara.Molecularandbiologicalpropertiesofvascularendothelialgrowthfactor[J ].JMolMed,1999,77:527-543.
[30]贾勇,初同伟,周跃,等.Ad-huVEGF121基因转染对兔坏死股骨头血流的影响.第三军医大学学报,2005,27(9):885-887.
[31]Peng H,Wright V,Usas A,et al·Synergistic enhancement and bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4.J Clin Invest,2002,110(6):751-759.
[32]马克昌,冯坤,朱太咏.骨生理学[M].郑州:河南医科大学出版社,2000.119-120.
[33]周强,石国华,杨柳.BMP及TGF2B复合生物材料治疗股骨头坏死的组织学观察.第三军医大学学报,2002,24(5):567-570.
[34]白志刚.细胞因子治疗非创伤性股骨头缺血坏死的研究进展.中国矫形外科杂志,2006,14(3):213-215.
[35]陈可新.股骨头缺血性坏死的手术治疗研究进展.中医正骨,2006,18(4):61-63.
[1]WikesCH,VisscherMB.Some physiological aspects of bone marrowpressure[J].J Bone Joint Surg(Am),1975,57(1):49-57.
[2]PlenkHJR,GstettnerM,GrossschmidtK,etal.Magneticresonanceim-agingandhisto logyofrepairinfemoralheadosteonecrosis[J]. ClinOrthop,2001,386(5):42-53.
[3]董天华,郑召民,译. 骨坏死病因诊断与治疗. 郑州: 河南医科大学出版社,1999;219-228
[4]Ruch DS,Satterfield W,The use of arthroscopy to document accurate posi-tion of core decompression of the hip. Arthroscopy 1998;14(6):617
[5]Mont MA,Ragland PS, Etienne G. Core decompression of the femoral head for osteonecrosis using percutaneous multiple small-diameter drilling. Clin Orthop Relat Res 2004;429:131
2 Mont MA, Hungerford DS. Non-traumatic avascular necrosis of femoralhead. J Bone Joint Surg 1995;77(3):957
[6]Steinberg ME,Larcom PG,Strafford B, et al. Core decompression with bone grafting for osteonecrosis of the femoral head. Clin Orthop Relat Res2001;(386):71
[7] Lieberman JR,Conduah A,Urist MR,Treatment of osteonecrosis of the femoral headwith core decompression and human bone morphogenetic protein. Clin Orthop RelatRes 2004;429:139
[8]FicatRP. Idiopathicbonenecrosisofthefemoralhead:Earlydiagnosisandtreatment[J]. JBoneJointSurg(Br),1985,67(1):3-9.
[9]LaverniaCJ,SierraRJ. Core decompression inatraumatico steonecrosis of the hip[J]. JArthropLasty,2000,15(2):171-178.
[10]SpecchiulliF. Core decompression in the treatment of necrosis of the femoral head. Long-term results[J]. ChirOrganiMov,2000,85(4):395-402.
[11] AignerN,SchneiderW,EberlV,etal. Coredecompressioninearlystagesoffemoralheadosteonecrosis-anMRI-controlledstudy[J]. IntOrthop,2002,26(1):31-38.
[12]MontMA,CarboneJJ,FairbankAC. Coredecompressionvs. nonopera-tivemanagementforavascularnecrosisofthefemoralhead[J]. ClinOrthop,1996,32:169-178.
[13]SternbergME,LarcomPG,StraffordB,etal. Coredecompressionwithbonegraftingforosteonecrosisofthefemoralhead[J]. ClinOrthop,2001,386(5):71-79.
[14]SchneiderW,BreitenseherM,EngelA,etal. Thevalueofcoredecom-pressionintreatmentoffemurheadnecrosis[J]. Orthopade,2000,29(5):420-429.
[15]Maniwa S,Nishikori T,Furukawa S,et al. Evaluation of core decompression for early osteonecrosis of the femoral head. Arch Orthop Trauma Surg 2000;120(5-6):241
[16]MontMA,Fairbank AC, Petri M,et al. Core decompression for osteonecrosis of the femoral head in systemic lupus erythematosus. Clin Orthop Relat Res 1997;(334):91
[17] Powell ET,Lanzer WL,Mankey MG. Core decompression for early osteonecrosis of the hip in high risk patients,Clin Orthop Relat Res 1997;(335):181
[18]Stylees LA,Vichinsky EP. Core decompression in avascular necrosis of the hip in sickle-cell disease. Am J Hematol 1996;52(2): 103
[19]MontMA,Jones LC,Pacheco I, et al. Radiographic predictors of outcome of core decompression for hips with osteonecrosis stageⅢ. CIin Orthop Relat Res 1998;(354):159
[1]李峻辉,宁亚功,贺斌,等.介入等综合治疗激素性股骨头坏死的实验研究[J].西南国防医药,2004,14(2):127.
[2]李子荣,张念非,岳得波,等.激素性股骨头坏死动物模型诱导和观察[J].中华外科杂志,1995,33(8):485-487.
[3]李卫哲,李景南,张新.抗凝药物预防激素所致股骨头坏死[J].吉林大学学报(医学版),2003,29(4):475.
[4]Nakagawa M,Kaneda T,Arakawa T,et al.Vascular endothelial growth factor directly enhances osteoclastic bone resorption and sur-vival of mature osteoclasts.Febs Letters,2000,473(3):161-164.
[5]ZhanQx,MagovernCJ,MackCA,etal.Yascular endothelial growth factor angiogenesis[J].JSurgRes,1997,67:147-154.
[6]马克昌,冯坤,朱太咏.骨生理学[M].郑州:河南医科大学出版社,2000.119-120.
[1]CreussRL.osteonecrosls of boneurrentconceptastoetiology and Pathegenesis.ClinorthoP,1986,208:30-33.
[2]Boss JH.Osteonecrosis of the femoral head of Labora-tory Animals Vet Pathol[J].Imissel -evich,2003,40,345-354
[3]贺西京.肾上皮质激素引起股骨缺血坏死的机制实验研究[J].中华骨科杂志,1992,12(6):440-443.
[4]Cui Q,Wang GJ,Su CC,et al.The Otto Autranc Award Lovastatin prevents steroid induced adipogenesis and osteonecrosis[J].Clin orthop relat Res,1997,344:8-19.
[5]李洪涛,王心生.鸡激素性股骨头缺血性坏死动物模型的建立[J].实验动物科学与管理,1999,16(1);22-24
[6]Conzemius MG,Brown TD,Zhang Y,Robinson RA.A new animal model of femoral head osteonecrosis:one that progresses to human-like mechanical failure[J].J Orthop Res.2002,20(2):303-309.
[7]牛敬才,尚希福,孔荣,等.一种新型的股骨头坏死动物模型.中国临床保健杂志,2006,9(2)137-138.
[8]TaKaoKa T,Yashioka T,Hosoya T,et al.The repair process in experimentally induced avascular necrosis ofthe femoral head in dogs[J].Arch orthop,1981,99(2):109-115.
[9]杨述华,杨操,许伟华,等.液氮冷冻建立兔股骨头缺血坏死模型[J].中国矫形外科杂志,2001,8(1):48-49.
[10]Masatsugu S,Toru H,Mihara KJ,et al.Etiologic factors in femoral head osteonecrosis in growing rats J[J].Orthop,2000(5):52-56.
[11]Miyanishi K,Yamamoto T,lrisa T,Motomura G,Jingushi S,Sueishi K,Iwamoto Y.Effects of different corticosteroids on the development of osteonecrosis in rabbits[J].Rheu -matology(Oxford).2005,44(3):332-336
[12]陈彦华,殷惠芬,王式鲁.马血清加激素诱导股骨头缺血性坏死动物模型的实验研究.山东中医药大学学报,2003,27(3):222-223
[1]Zhan Qx,Magovern CJ,Mack CA,et al.Vascular endothelial growth factor angiogene -sis[J].J Surg Res,1997,67:147-154.
[2]Napoleone Ferrara.Molecular and biological properties of vascular endothelial growth fact -or[J].J Mol Med,1999,77:527-543.
[3]Josko J,Gwozdz B,Jedrzejowska-Szypulka H,et al.Vascular endothelial growth factor (VEGF)and its effect on angiogen-esis[J].Med Sci Monit,2000,6(5):1047-1052.
[4]马克昌,冯坤,朱太咏.骨生理学[M].郑州:河南医科大学出版社,2000.119-120.
[5]UristMR,etal.Bone call differentiation and growth factor[J].Science.1983,320:680.
[6]Nilsson SK,Dooner MS,Weier HU,et al.Cells capable of bone production engraft from whole bone marrow transplants in nonablated mice[J].J Exp Med,1999,189:729-734.
[7]Urist MR.Orthopaedic management of osteoporosis in ostmenoausal women[J].Clin Endocrinol Metab,1973.2:159-176.
[8]薛元锁,时述山,李亚非,等.激素性股骨头坏死病程中骨形态发生蛋白-2的改变及意义[J].中华实验外科杂志,2000,17(5):455-456.
[9]周强,石国华,杨柳,等.复合多孔生物材料在股骨头坏死模型中诱导成骨的观察[J].中华外科杂志,2002,40(6):458-464.
[10]胡彤宇,扈文海,李建衡,等.随心减压BMP植入治疗股骨头坏死的血流量及病理改变[J].中国矫形外科杂志,2002,9(4):370.
[11]Aaron A,Wiedel J.Allograft use in orthopedic surgery[J].Orthopedics,1994,17:41-48.
[12]Wilson AG,Symons JA,Mc Dowell T,et al.Effects of a polymorphism in the humman tumor necrosis factor alpha promoter on transcriptional activation[J].Proc Natl Acad Sci USA,1997,94:3195-3199.
[13]Turner DM,Williams DM,Sankaran D,et al.An mvestingation of polymorphism in the interleukin-10 gene promoter[J].Eur J lmmuno Genet,1997,24:1-8.
[2]刘少军,袁浩.股骨头坏死的中医临床思路与方法探讨.中国医药学报,2002,17(1):44-47.
[3]左萍萍,吴业华,李学坤,等.新骨生胶囊治疗股骨头坏死的药理研究.中国康复理论与实验,2002,8(1):11-12.
[4]茆军,郭玉成.补肾通络汤治疗早期非创伤性股骨头坏死的临床研究.河北医学,2002,8(7):672-673.
[5]齐振熙,曹阳.不同治法对激素性股骨头坏死血液流变学及血脂影响的实验研究.中国中医骨伤科杂志,2001,9(5):39-31.
[6]曾炎辉.补肾活血汤治疗中老年股骨头缺血性坏死临床观察.广州中医药大学学报,2005,22(2):96.
[7]李清文,激素性股骨头缺血性坏死微观瘀血诊治之我见.湖南中医学院学报.1999:19(1):28-29
[8]何维英,季卫峰,童培建.保守治疗股骨头坏死的疗效观察.浙江中医学院学报,2003,27(5):33.
[9]肖正权.健骨颗粒治疗无菌性股骨头坏死120例临床观察.中医药学报,2002,30(4):33.
[10]洪加源,许书亮,阮景绰,等.复元散对激素性股骨头坏死脂代谢的影响.中医正骨,2001,13(4):6-8.
[11]王玉华.浅述SARS愈后股骨头坏死的综合治疗.北京中医药大学学报(中医临床版),2004,9,11(3):35-36.
[12]邓沂,张晓刚,任远,等.中医对股骨头坏死的认识.甘肃中医学报,1988, 15(4):54-56.
[13]徐传毅.袁浩教授以血瘀论治激素性股骨头坏死经验.中医约学刊,2003,21(2):194-195.
[14]刘少军,袁浩.股骨头坏死的中医临床思路与方法探讨.中国医药学报,2002,17(1):44-47.
[15]乔美莲.针灸治疗激素性股骨头坏死.山西中医学院学报,2003,4(2):34.
[16]张晓刚,任远,王刚,等.生骨再造散对激素性股骨头坏死家兔血脂的影响.中国骨伤,2001,14(3):148-149.
[17]汤耿民,王胜利,李同生,等.健骨生丸治疗股骨头坏死Ⅱ期临床研究,中国中医骨伤科杂志,1998,6(1):16-19
[18]王峰,丁锷,李保泉.股骨头缺血性坏死的中医分型和治疗.中医正骨,2005,17(7):24.
[19]马素英.马氏骨片治疗激素性股骨头坏死1323例[J].中医骨伤,1993,6(3):32.
[20]张铁刚.股骨头坏死中医三型分治的临床总结[J].中国中医约结合外科杂志,1998,12(4):6
[21]李雄.袁浩教授对股骨头坏死中医药论治的学术思想[J].中国中医骨伤科,1999,7(1):61.
[22]王平,高红艳.辨证分型治疗激素性股骨头坏死117例[J].上海中医药大学学报,2003,17(1):36.
[23]王峰,周章武.丁锷教授诊治股骨头坏死学术经验[J].安徽中医学院学报,1999,18(5):47.
[24]王峰,丁锷,李保泉.股骨头缺血性坏死的中医分型和治疗.中医正骨,2005,17(7):24.
[25]杨晓娟.黄芪生骨汤治疗股骨头坏死179例疗效观察.时珍国医药.1998,9(6):503
[26]杨述华.骨坏死学[M].北京:人民卫生出版社,2002:7-8.
[1]Meyers MH.Osteonecrosis of the femoral head.Pathogenesis and Long-term results of treatment,[J].Clinical Orthopaedics snd Related Research,1988(231):51-61.
[2]Cruess RL,Osteonecrosis of bone.Current concepts as to etiology and pathogenesis.[J].Clinical Orthopaedics and Related Research,1986(208):30-39.
[3]林乔龄,张嵩图,陈联源,等.股骨头缺血坏死发病机理研究[J],中国骨伤,2001,14(3):150-151..
[4]洪加源,郭林新,康两期.激素性股骨头坏死骨代谢变化的实验研究[J].骨与关节损伤杂志,2001,26(5):365-368.
[5]Climcher MJ,Kenzora JE.The biology of ostenecrosis of the human femoral head and its clinical impalcations.Ⅲ.Discussion of the etiology and genesis of the pathological seguelae;comments on treatment[J],Clinical Orthopaedics and Related Research,1979(140):273-312.
[6]Jones JP.Fat embolism and osteonecrosis.[J].The Orthopedic Clinics of North America,1985,16(4):595-633.
[7]王坤正,毛履真,胡长根.激素性股骨头缺血性坏死发病机制的实验研究[J].中华外科杂志,1994,32(9):515-517.
[8]贺西京,毛履真,王坤正.激素性股骨头坏死与骨细胞脂肪变性的实验研究[J].中华骨科杂志,1996,16(1):44-46..
[9]文良元,黄公怡,路奎元.激素性股骨头坏死的发病机制研究[J].中华外科杂志,1998,36(1):39-41.
[10]Beisiegel U,Spector A.Bong:a forgotten organ in lipidology.[J].Curr Opin Lipidol,2002,13(3):239-240.
[11]Cui Q,Wang GJ,Balian G.Steroid-induced adipogenesis in a pluripotential cell line from bone marrow[J].J Bone Joint Surg Am,1997,79(7):1054-1063.
[12]Cui Q,Wang GJ,Balian G,Pluripotential marrow cells produce adipocytes when transplanted into steroid-treated mice[J].Cnonect Tissue Res,2000,41(1):45-56.
[13]Jones JP.Intravascular coagulation and osteonecrosis.[J].Clinical Orthopaedics and Related Research,1992(277):41-53.
[14]Jones JP.Fat embolism,intravascular coagulation,and osteonecrosis.[J].Clinical Orthopaedics and Related Research,1993(292):294-308.
[15]Jones JP.Concepts of etiology and early pathogenesis of osteonecrosis,[J].Instructional Course Lectures,1994,(43):499-512.
[16]Jones JP.Coagulopathies and osteonecrosis.[J].Acta Orthopaedica Belgica,1999,65Suppl 15-8.
[17]Jones LC,Mont MA,Le TB,et al.Procoagulants and osteonecrosis,[J].The Journal of Rheumatology,2003,30(4):783.
[18]Weinstein RS,Nicholas RW,Manolagas SC,Apoptosis of osteocytes in glucocorticoid-induced osteonecrosis of the hip.[J].The Journal of Clinical Endocrinology and Metabolism,2000,85(8):2907-2912.
[19]Agarwala S,Sule A,Pai BU,Joshi VR,et al.Study of alendronate in avascular necrosis of bone[J].J Assoc Physicians India,2001(49):949-950.
[20]Eberhardt AW,Yeager Jones A,Blair HC,Regional trabecular bone matrix degeneration and osteocyte death in femora of glucocorticoid-treated rabbits.[J].Endocrinology,2001,142(3):1333-1340.
[21]Pritchett JW.Statin therapy decreases the risk of osteonecrosis inpatients receiving steroids.Clin Orthop Relat Res,2001,38(6):173-178.
[22]王卫东,廖文胜,王义生.辛伐他汀预防激素性股骨头坏死的实验研究.郑州大学学报(医学版),2004,39(3):473-475.
[23]李卫哲,李景南,张新.抗凝药物预防激素所致股骨头坏死.吉林大学学报(医学版),2003,29(4):475-476.
[24]Masuhara K,Nakata K,Yamasaki S,et al.Involvement of plateletactivation in experimental osteonecrosis in rabbits.Int J ExpPathol,2001,82(5):303-308.
[25]李晓辉,炎跃昆,宋跃明.碱性成纤维细胞生长因子复合部分脱蛋白骨增强兔股骨头骨缺损修复作用的研究.中国修复重建外科杂志,2005,19(3):183-186.
[26]Whitlock PR,Hackett NR,Leopold PL,et al.Adenovirus-medi-ated transfer of a minigene expressing multiple isoforms of VEGF is more effective at inducing angiogenesis than comparable vectors expressing individual VEGF cDNAs.Mol The,2004,9(1):67-75.
[27]Nakagawa M,Kaneda T,Arakawa T,et al.Vascular endothelialgrowth factor directly enhances osteoclastic bone resorption and sur-vival of mature osteoclasts.Febs Letters,2000,473(3):161-164.
[28]ZhanQx,MagovernCJ,MackCA,etal.Vascularendothelialgrowthfactorangiogenesis[J].J Su rgRes,1997,67:147-154.
[29]NapoleoneFerrara.Molecularandbiologicalpropertiesofvascularendothelialgrowthfactor[J ].JMolMed,1999,77:527-543.
[30]贾勇,初同伟,周跃,等.Ad-huVEGF121基因转染对兔坏死股骨头血流的影响.第三军医大学学报,2005,27(9):885-887.
[31]Peng H,Wright V,Usas A,et al·Synergistic enhancement and bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4.J Clin Invest,2002,110(6):751-759.
[32]马克昌,冯坤,朱太咏.骨生理学[M].郑州:河南医科大学出版社,2000.119-120.
[33]周强,石国华,杨柳.BMP及TGF2B复合生物材料治疗股骨头坏死的组织学观察.第三军医大学学报,2002,24(5):567-570.
[34]白志刚.细胞因子治疗非创伤性股骨头缺血坏死的研究进展.中国矫形外科杂志,2006,14(3):213-215.
[35]陈可新.股骨头缺血性坏死的手术治疗研究进展.中医正骨,2006,18(4):61-63.
[1]WikesCH,VisscherMB.Some physiological aspects of bone marrowpressure[J].J Bone Joint Surg(Am),1975,57(1):49-57.
[2]PlenkHJR,GstettnerM,GrossschmidtK,etal.Magneticresonanceim-agingandhisto logyofrepairinfemoralheadosteonecrosis[J]. ClinOrthop,2001,386(5):42-53.
[3]董天华,郑召民,译. 骨坏死病因诊断与治疗. 郑州: 河南医科大学出版社,1999;219-228
[4]Ruch DS,Satterfield W,The use of arthroscopy to document accurate posi-tion of core decompression of the hip. Arthroscopy 1998;14(6):617
[5]Mont MA,Ragland PS, Etienne G. Core decompression of the femoral head for osteonecrosis using percutaneous multiple small-diameter drilling. Clin Orthop Relat Res 2004;429:131
2 Mont MA, Hungerford DS. Non-traumatic avascular necrosis of femoralhead. J Bone Joint Surg 1995;77(3):957
[6]Steinberg ME,Larcom PG,Strafford B, et al. Core decompression with bone grafting for osteonecrosis of the femoral head. Clin Orthop Relat Res2001;(386):71
[7] Lieberman JR,Conduah A,Urist MR,Treatment of osteonecrosis of the femoral headwith core decompression and human bone morphogenetic protein. Clin Orthop RelatRes 2004;429:139
[8]FicatRP. Idiopathicbonenecrosisofthefemoralhead:Earlydiagnosisandtreatment[J]. JBoneJointSurg(Br),1985,67(1):3-9.
[9]LaverniaCJ,SierraRJ. Core decompression inatraumatico steonecrosis of the hip[J]. JArthropLasty,2000,15(2):171-178.
[10]SpecchiulliF. Core decompression in the treatment of necrosis of the femoral head. Long-term results[J]. ChirOrganiMov,2000,85(4):395-402.
[11] AignerN,SchneiderW,EberlV,etal. Coredecompressioninearlystagesoffemoralheadosteonecrosis-anMRI-controlledstudy[J]. IntOrthop,2002,26(1):31-38.
[12]MontMA,CarboneJJ,FairbankAC. Coredecompressionvs. nonopera-tivemanagementforavascularnecrosisofthefemoralhead[J]. ClinOrthop,1996,32:169-178.
[13]SternbergME,LarcomPG,StraffordB,etal. Coredecompressionwithbonegraftingforosteonecrosisofthefemoralhead[J]. ClinOrthop,2001,386(5):71-79.
[14]SchneiderW,BreitenseherM,EngelA,etal. Thevalueofcoredecom-pressionintreatmentoffemurheadnecrosis[J]. Orthopade,2000,29(5):420-429.
[15]Maniwa S,Nishikori T,Furukawa S,et al. Evaluation of core decompression for early osteonecrosis of the femoral head. Arch Orthop Trauma Surg 2000;120(5-6):241
[16]MontMA,Fairbank AC, Petri M,et al. Core decompression for osteonecrosis of the femoral head in systemic lupus erythematosus. Clin Orthop Relat Res 1997;(334):91
[17] Powell ET,Lanzer WL,Mankey MG. Core decompression for early osteonecrosis of the hip in high risk patients,Clin Orthop Relat Res 1997;(335):181
[18]Stylees LA,Vichinsky EP. Core decompression in avascular necrosis of the hip in sickle-cell disease. Am J Hematol 1996;52(2): 103
[19]MontMA,Jones LC,Pacheco I, et al. Radiographic predictors of outcome of core decompression for hips with osteonecrosis stageⅢ. CIin Orthop Relat Res 1998;(354):159
[1]李峻辉,宁亚功,贺斌,等.介入等综合治疗激素性股骨头坏死的实验研究[J].西南国防医药,2004,14(2):127.
[2]李子荣,张念非,岳得波,等.激素性股骨头坏死动物模型诱导和观察[J].中华外科杂志,1995,33(8):485-487.
[3]李卫哲,李景南,张新.抗凝药物预防激素所致股骨头坏死[J].吉林大学学报(医学版),2003,29(4):475.
[4]Nakagawa M,Kaneda T,Arakawa T,et al.Vascular endothelial growth factor directly enhances osteoclastic bone resorption and sur-vival of mature osteoclasts.Febs Letters,2000,473(3):161-164.
[5]ZhanQx,MagovernCJ,MackCA,etal.Yascular endothelial growth factor angiogenesis[J].JSurgRes,1997,67:147-154.
[6]马克昌,冯坤,朱太咏.骨生理学[M].郑州:河南医科大学出版社,2000.119-120.
[1]CreussRL.osteonecrosls of boneurrentconceptastoetiology and Pathegenesis.ClinorthoP,1986,208:30-33.
[2]Boss JH.Osteonecrosis of the femoral head of Labora-tory Animals Vet Pathol[J].Imissel -evich,2003,40,345-354
[3]贺西京.肾上皮质激素引起股骨缺血坏死的机制实验研究[J].中华骨科杂志,1992,12(6):440-443.
[4]Cui Q,Wang GJ,Su CC,et al.The Otto Autranc Award Lovastatin prevents steroid induced adipogenesis and osteonecrosis[J].Clin orthop relat Res,1997,344:8-19.
[5]李洪涛,王心生.鸡激素性股骨头缺血性坏死动物模型的建立[J].实验动物科学与管理,1999,16(1);22-24
[6]Conzemius MG,Brown TD,Zhang Y,Robinson RA.A new animal model of femoral head osteonecrosis:one that progresses to human-like mechanical failure[J].J Orthop Res.2002,20(2):303-309.
[7]牛敬才,尚希福,孔荣,等.一种新型的股骨头坏死动物模型.中国临床保健杂志,2006,9(2)137-138.
[8]TaKaoKa T,Yashioka T,Hosoya T,et al.The repair process in experimentally induced avascular necrosis ofthe femoral head in dogs[J].Arch orthop,1981,99(2):109-115.
[9]杨述华,杨操,许伟华,等.液氮冷冻建立兔股骨头缺血坏死模型[J].中国矫形外科杂志,2001,8(1):48-49.
[10]Masatsugu S,Toru H,Mihara KJ,et al.Etiologic factors in femoral head osteonecrosis in growing rats J[J].Orthop,2000(5):52-56.
[11]Miyanishi K,Yamamoto T,lrisa T,Motomura G,Jingushi S,Sueishi K,Iwamoto Y.Effects of different corticosteroids on the development of osteonecrosis in rabbits[J].Rheu -matology(Oxford).2005,44(3):332-336
[12]陈彦华,殷惠芬,王式鲁.马血清加激素诱导股骨头缺血性坏死动物模型的实验研究.山东中医药大学学报,2003,27(3):222-223
[1]Zhan Qx,Magovern CJ,Mack CA,et al.Vascular endothelial growth factor angiogene -sis[J].J Surg Res,1997,67:147-154.
[2]Napoleone Ferrara.Molecular and biological properties of vascular endothelial growth fact -or[J].J Mol Med,1999,77:527-543.
[3]Josko J,Gwozdz B,Jedrzejowska-Szypulka H,et al.Vascular endothelial growth factor (VEGF)and its effect on angiogen-esis[J].Med Sci Monit,2000,6(5):1047-1052.
[4]马克昌,冯坤,朱太咏.骨生理学[M].郑州:河南医科大学出版社,2000.119-120.
[5]UristMR,etal.Bone call differentiation and growth factor[J].Science.1983,320:680.
[6]Nilsson SK,Dooner MS,Weier HU,et al.Cells capable of bone production engraft from whole bone marrow transplants in nonablated mice[J].J Exp Med,1999,189:729-734.
[7]Urist MR.Orthopaedic management of osteoporosis in ostmenoausal women[J].Clin Endocrinol Metab,1973.2:159-176.
[8]薛元锁,时述山,李亚非,等.激素性股骨头坏死病程中骨形态发生蛋白-2的改变及意义[J].中华实验外科杂志,2000,17(5):455-456.
[9]周强,石国华,杨柳,等.复合多孔生物材料在股骨头坏死模型中诱导成骨的观察[J].中华外科杂志,2002,40(6):458-464.
[10]胡彤宇,扈文海,李建衡,等.随心减压BMP植入治疗股骨头坏死的血流量及病理改变[J].中国矫形外科杂志,2002,9(4):370.
[11]Aaron A,Wiedel J.Allograft use in orthopedic surgery[J].Orthopedics,1994,17:41-48.
[12]Wilson AG,Symons JA,Mc Dowell T,et al.Effects of a polymorphism in the humman tumor necrosis factor alpha promoter on transcriptional activation[J].Proc Natl Acad Sci USA,1997,94:3195-3199.
[13]Turner DM,Williams DM,Sankaran D,et al.An mvestingation of polymorphism in the interleukin-10 gene promoter[J].Eur J lmmuno Genet,1997,24:1-8.